Literature DB >> 632576

The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.

P E Lipsky, M Ziff.   

Abstract

The effect of D-penicillamine on in vitro mitogen-triggered human peripheral blood lymphocyte DNA synthesis was examined. D-penicillamine caused a modest degree of inhibition of responsiveness. Since D-penicillamine avidly chelates copper, a possible additive effect of D-penicillamine and copper salts on mitogen-induced lymphocyte proliferation was investigated. The addition of various copper salts to D-penicillamine-containing cultures resulted in a marked augmentation in the degree of inhibition observed. Specificity for the synergy between D-penicillamine and copper was suggested by the failure of iron, zinc, or gold salts to augment the inhibition produced by D-penicillamine alone. However, a number of other thiols, but not disulfides, could substitute for D-penicillamine in inhibiting mitogen responsiveness in the presence of copper salts. Preincubation of peripheral blood mononuclear cells with D-penicillamine and CuSO4 resulted in diminished mitogen responsiveness on subsequent culture in the absence of the inhibitors. Data are presented to indicate that preincubation with D-penicillamine and CuSO4 directly affected the ability of the T lymphocytes to respond to mitogens but did not alter the capacity of the monocytes to act as accessory cells in this response.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Wilson's disease: A review of what we have learned.

Authors:  Kryssia Isabel Rodriguez-Castro; Francisco Javier Hevia-Urrutia; Giacomo Carlo Sturniolo
Journal:  World J Hepatol       Date:  2015-12-18

2.  Indian childhood cirrhosis: copper ingestion, penicillamine treatment and prevention.

Authors:  M S Tanner
Journal:  Indian J Pediatr       Date:  1987 Jul-Aug       Impact factor: 1.967

3.  Effects of D-penicillamine on growth and cell cycle kinetics of cultured rabbit articular chondrocytes.

Authors:  P Jaffray; X Ronot; M Adolphe; J Fontagne; P Lechat
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

4.  Evidence against HLA and immunological dependence of disease outbreak in SLE. Immunological characterisation of identical twins clinically discordant for SLE.

Authors:  E Soppi; J Eskola; A Lehtonen
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

5.  Heberden Society. The Heberden Round April 1979.

Authors: 
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

6.  Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.

Authors:  J A Cuthbert; P E Lipsky
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.

Authors:  T Akamatsu; T Matsubara; Y Saegusa; K Mizuno
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  A T-cell response to the anti-arthritic drug penicillamine in the mouse: requirements for generation of the drug-derived antigen.

Authors:  C A O'Donnell; J W Coleman
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

9.  Production of antibodies specific for Fc, Fab', and streptokinase-streptodornase in vitro by peripheral blood cells from patients with rheumatoid arthritis and normal donors. Identification of immune complexes in culture supernatants containing hidden antibodies reactive with Fab' fragments of immunoglobulin G.

Authors:  H H Birdsall; R D Rossen
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  Proteoglycan biosynthesis by rabbit articular chondrocytes treated with D-penicillamine.

Authors:  P Legendre; M Bouakka; M Langris; J P Pujol; R Beliard; G Loyau; J Bocquet
Journal:  Agents Actions       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.